Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

Suad Hannawi, Linda Saf Eldin, Alaa Abuquta, Ahmad Alamadi, Sally A. Mahmoud, Aala Hassan, Shuping Xu, Jian Li, Dongfang Liu, Adam Abdul Hakeem Baidoo, Dima Ibrahim, Mojtaba Alhaj, Yuanxin Chen, Qiang Zhou and Liangzhi Xie ()
Additional contact information
Suad Hannawi: Al Kuwait-Dubai (ALBaraha) Hospital
Linda Saf Eldin: Al Kuwait-Dubai (ALBaraha) Hospital
Alaa Abuquta: Al Kuwait-Dubai (ALBaraha) Hospital
Ahmad Alamadi: Al Kuwait-Dubai (ALBaraha) Hospital
Sally A. Mahmoud: G42 Healthcare
Aala Hassan: Al Kuwait-Dubai (ALBaraha) Hospital
Shuping Xu: Sinocelltech Ltd.
Jian Li: Sinocelltech Ltd.
Dongfang Liu: Sinocelltech Ltd.
Adam Abdul Hakeem Baidoo: Sinocelltech Ltd.
Dima Ibrahim: Burjeel Medical City
Mojtaba Alhaj: Burjeel Medical City
Yuanxin Chen: Sinocelltech Ltd.
Qiang Zhou: Sinocelltech Ltd.
Liangzhi Xie: Sinocelltech Ltd.

Nature Communications, 2024, vol. 15, issue 1, 1-1

Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-024-44729-x Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-44729-x

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-024-44729-x

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().